Latest News

iAssay, Inc. Joins MetroConnect to Accelerate International Growth

iAssay, Inc. joins MetroConnect to accelerate international growth

Export assistance program to support iAssay, Inc. with growth in European and Asian medical diagnostics markets

San Diego – Today, iAssay, Inc. has been named as one of 15 San Diego companies participating in MetroConnect, World Trade Center San Diego (WTCSD)’s comprehensive export assistance program that helps local companies accelerate their international growth. WTCSD, San Diego City Councilmember Raul Campillo, and nearly 100 community leaders came together to welcome the new cohort today.

This program will allow iAssay, Inc. to attend international trade shows, expand trade partnerships in current and new foreign markets.

“We are excited for the opportunity to participate in the MetroConnect program,” said Lonnie Adelman, Founder and CEO of iAssay, Inc. “The in-kind services offered through the program and being able to collaborate with our fellow Cohort VI companies to promote successes all the way around is what makes the program most attractive to iAssay.

“We applaud iAssay, Inc. for taking the next step in going global,” said Nikia Clarke, executive director of World Trade Center San Diego. “As the San Diego economy continues to recover from the pandemic, we are optimistic about the future. Thanks to JPMorgan Chase and Procopio, the MetroConnect program will continue to build on this momentum and help ensure San Diego’s small and mid-sized businesses have the tools needed to weather future economic downturns, grow quality jobs, and share San Diego-made innovation with the world.”

Since the program’s debut in 2015, 80 MetroConnect alumni have collectively added 269 new jobs to the region, signed more than 543 new contracts, and set up 22 new overseas facilities. On average, cohort companies grow their exports by an average 63 percent and revenues by 40 percent as part of the program. Alumni include Blue Sky Network, Aira (acquired by Blue Diego Investment Group),, Modern Times, Dr. Bronner’s, Cypher Genomics (acquired by Human Longevity Inc.), Planck Aerosystems, Bitchin’ Sauce, and many more.

“I’m proud to support and welcome WTCSD’s new cohort and look forward to seeing the companies’ impact on a global scale,” said San Diego City Councilmember Raul Campillo. “Programs like MetroConnect help ensure the world knows just what San Diego is made of—innovative, high-impact products and services across a wide range of industries.”

iAssay, Inc.joins a cohort of 14 other companies representing a unique cross-section of San Diego’s industries, from genomics to manufacturing to craft brewing – each with plans to take San Diego innovation global.

Program participants receive a $5,000 grant, a one-year subscription to premium translation software, discounts on international travel, executive workshops on export-related topics and access to a global mentor and service provider network. Participants will also have the opportunity to participate in the program’s final competition – the MetroConnect Grand Prize PitchFest – which will grant an additional $25,000 to help one company further advance its international efforts.

“Since its launch, the City of San Diego has been a proud supporter of MetroConnect and the nearly 100 businesses it has helped grow internationally,” said San Diego Mayor Todd Gloria. “As Mayor, I’m committed to supporting San Diego’s small businesses on our road to recovery; and international connectivity is an important tool in building economic resilience.”

The MetroConnect program is highly competitive, with just 15 companies selected based on a variety of criteria, including interest in new markets, interest in targeted metro markets, assessed impact of funds, current international traction and more. Applicants were assessed by a panel of judges, including senior level representatives from Biocom, Connect, CMTC, U.S. Commercial Service, Procopio, and Mitsubishi Electric.

MetroConnect is co-underwritten by JPMorgan Chase & Co. and Procopio, with additional support provided by American Airlines, British Airways, City of San Diego, Japan Airlines, Mitsubishi Electric, Qualcomm, San Diego and Imperial SBDC Network, SYSTRAN, Takeda Pharmaceuticals, Taylor Guitars, United Kingdom Government Office, YCP Solidiance and more.

About iAssay, Inc.

Privately-held iAssay® develops Amazon AWS IT Systems and Cloud connected portable medical devices as a system that enhances the type of Point-of-Care Test (POCT) clinical diagnostics experienced by millions of people and their healthcare providers at pharmacies, doctors’ offices, and at workplaces during the COVID-19 pandemic. Battery-powered, devices are test agnostic, enabling a variety of drug screening and clinical tests by multi-manufacturers to be adapted to a single device. The System drives interoperability! Multi-tech/format POCT cartridges commercialized by hundreds of companies are can be onboarded using iAssay® designed devices and adaptors. iAssay® AWS Cloud validates devices before testing can start, then captures raw data, time/date stamped results available through worldwide internet portals.

About World Trade Center San Diego

World Trade Center San Diego (WTCSD) operates as an affiliate of San Diego Regional Economic Development Corporation (EDC). WTCSD works to further San Diego’s global competitiveness by cultivating a pipeline of export-ready firms, attracting, and retaining foreign investment and increasing San Diego’s global profile abroad.